A California jury has just concluded a lawsuit against drug and consumer health company Johnson & Johnson. However, the verdict turned out to be the biggest blow the safest baby powder brand on the market has ever received. The jury sided with the plaintiffs who claimed that the company’s talc products induce ovarian cancer when applied for feminine hygiene. J&J plans to file an appeal as the company is certain that it uses safe ingredients only. Science so far delivered scant evidence in this aspect.
Johnson & Johnson Company Intends to Appeal the $417 Million Settlement Regarding Its Baby Powder Inducing Ovarian Cancer Risks
The Los Angeles Superior Court ruled on Monday for $417 million settlement as compensation for California citizen Eva Echeverria. The allegations concerned Johnson & Johnson and its baby powder products.
There are other 4,800 standby cases over talc products that are allegedly increasing risks of cancer. Various law courts across Missouri have already demanded the company a total of $300 million in damage compensations.
However, J&J scored victories of its own as well. Back in May, the company managed to void similar allegations against it. Therefore, executives are going to use the outcome of this case to appeal all the other verdicts.
The American Cancer Society Found No Solid Study That Indicates Increased Cancer Risks among Talc Products
In conclusion, should people avoid using baby powder of talc products from now on? Studies so far delivered mixed results. Firstly, there is a kind of talc that contains asbestos which is carcinogenic. However, this mineral is no longer used for consumer products. The studies on asbestos-free talc haven’t reached a clear conclusion.
According to the American Cancer Society, the purified version of talc was subject to numerous studies as well. However, most of the research turned out to be biased as the collected data relied on women’s memory over several years of using such products.
The few papers based on objective facts found no significant increase cancer risks. However, the agency concluded that there is a need for more studies in this area.
Image source: 1